IFN-γ Induces PD-L1 Expression in Primed Human Basophils

被引:13
作者
Bonam, Srinivasa Reddy [1 ]
Chauvin, Camille [1 ]
Mathew, Mano J. [2 ]
Bayry, Jagadeesh [1 ,3 ]
机构
[1] Univ Paris, Sorbonne Univ, Ctr Rech Cordeliers, Inst Natl Sante & Rech Med, F-75006 Paris, France
[2] EFREI, F-94800 Villejuif, France
[3] Indian Inst Technol Palakkad, Dept Biol Sci & Engn, Palakkad 678623, India
关键词
human basophils; PD-L1; IFN-gamma; IL-3; IL-4; IL-13; IFNGR2; UP-REGULATION; OX40; LIGAND; INTERFERON-GAMMA; TH2; RESPONSES; B7-H1; ROLES; CELLS; ACTIVATION; MECHANISMS; COVID-19;
D O I
10.3390/cells11050801
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Programmed death-ligand 1 (PD-L1) plays a key role in maintaining immune tolerance and also in immune evasion of cancers and pathogens. Though the identity of stimuli that induce PD-L1 in various human innate cells and their function are relatively well studied, data on the basophils remain scarce. In this study, we have identified one of the factors, such as IFN-gamma, that induces PD-L1 expression in human basophils. Interestingly, we found that basophil priming by IL-3 is indispensable for IFN-gamma -induced PD-L1 expression in human basophils. However, priming by other cytokines including granulocyte-macrophage colony-stimulating factor (GM-CSF) and thymic stromal lymphopoietin (TSLP) was dispensable. Analyses of a published microarray data set on IL-3-treated basophils indicated that IL-3 enhances IFNGR2, one of the chains of the IFNGR heterodimer complex, and CD274, thus providing a mechanistic insight into the role of IL-3 priming in IFN-gamma -induced PD-L1 expression in human basophils.
引用
收藏
页数:15
相关论文
共 50 条
[31]   Triptolide reduces PD-L1 through the EGFR and IFN-?/IRF1 dual signaling pathways [J].
Xie, Yongli ;
Ding, Jiwei ;
Gao, Jieke ;
Zhang, Jiantao ;
Cen, Shan ;
Zhou, Jinming .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 118
[32]   Autophagy inhibition enhances PD-L1 expression in gastric cancer [J].
Wang, Xiaojuan ;
Wu, William K. K. ;
Gao, Jing ;
Li, Zhongwu ;
Dong, Bin ;
Lin, Xiaoting ;
Li, Yilin ;
Li, Yanyan ;
Gong, Jifang ;
Qi, Changsong ;
Peng, Zhi ;
Yu, Jun ;
Shen, Lin .
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2019, 38 (1)
[33]   The covalent modification of STAT1 cysteines by sulforaphane promotes antitumor immunity via blocking IFN-γ-induced PD-L1 expression [J].
Shi, Qing ;
Liu, Yajuan ;
Yang, Wanqi ;
Li, Yao ;
Wang, Chenji ;
Gao, Kun .
REDOX BIOLOGY, 2025, 81
[34]   Mechanisms regulating PD-L1 expression on tumor and immune cells [J].
Chen, Shuming ;
Crabill, George A. ;
Pritchard, Theresa S. ;
McMiller, Tracee L. ;
Wei, Ping ;
Pardoll, Drew M. ;
Pan, Fan ;
Topalian, Suzanne L. .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01)
[35]   Pentamethylquercetin inhibits Hepatocellular Carcinoma Progression and Adipocytes-induced PD-L1 Expression via IFN-γ Signaling [J].
Li, Zhi ;
Gao, Wen-Qi ;
Wang, Peng ;
Wang, Tian-Qi ;
Xu, Wen-Chao ;
Zhu, Xin-Yu ;
Liu, Hui .
CURRENT CANCER DRUG TARGETS, 2020, 20 (11) :868-874
[36]   Suppressed T-cell activation by IFN-γ-induced expression of PD-L1 on renal tubular epithelial cells [J].
Schoop, R ;
Wahl, P ;
Le Hir, M ;
Heemann, U ;
Wang, MH ;
Wüthrich, RP .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 (11) :2713-2720
[37]   RETRACTED: IFN-γ induces PD-L1 through p38/JNK/ERK signaling pathways and counteracts the tumor promoting effect mediated by PD-L1 in Glioblastoma (Retracted Article) [J].
Jia, Huafang ;
Xie, Xiaoli ;
Wang, Long ;
Wang, Lijuan ;
Che, Fengyuan .
COMPUTATIONAL INTELLIGENCE AND NEUROSCIENCE, 2022, 2022
[38]   PD-L1 Expression in Human Placentas and Gestational Trophoblastic Diseases [J].
Veras, Emanuela ;
Kurman, Robert J. ;
Wang, Tian-Li ;
Shih, Ie-Ming .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY, 2017, 36 (02) :146-153
[39]   YAP regulates PD-L1 expression in human NSCLC cells [J].
Miao, Jinbai ;
Hsu, Ping-Chih ;
Yang, Yi-Lin ;
Xu, Zhidong ;
Dai, Yuyuan ;
Wang, Yucheng ;
Chan, Geraldine ;
Huang, Zhen ;
Hu, Bin ;
Li, Hui ;
Jablons, David M. ;
You, Liang .
ONCOTARGET, 2017, 8 (70) :114576-114587
[40]   Cdk5 disruption attenuates tumor PD-L1 expression and promotes antitumor immunity [J].
Dorand, R. Dixon ;
Nthale, Joseph ;
Myers, Jay T. ;
Barkauskas, Deborah S. ;
Avril, Stefanie ;
Chirieleison, Steven M. ;
Pareek, Tej K. ;
Abbott, Derek W. ;
Stearns, Duncan S. ;
Letterio, John J. ;
Huang, Alex Y. ;
Petrosiute, Agne .
SCIENCE, 2016, 353 (6297) :399-403